DataMeds AI, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
DataMeds AI, Inc. (MEDS) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $2.64 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-17
- DataMeds AI, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $2.55M, a 280.01% increase year-over-year.
- DataMeds AI, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $90.06K, a 81.02% decline year-over-year.
- DataMeds AI, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $935.39K, a 73.69% increase year-over-year.
- DataMeds AI, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $1.15M, a 53.86% increase year-over-year.
- DataMeds AI, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $3.23M, a 106.68% increase from fiscal 2024.
- DataMeds AI, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $1.56M, a 12.22% decline from fiscal 2023.
- DataMeds AI, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $1.78M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $2.64M 10-Q · filed 2026-08-17 | $3.58M derived: sum of 3 quarters · filed 2026-08-17 | $4.73M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $90.06K 10-Q · filed 2026-05-19 | $1.03M derived: sum of 2 quarters · filed 2026-05-19 | $2.18M derived: sum of 3 quarters · filed 2026-05-19 | $2.85M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $935.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $2.09M derived: sum of 2 quarters · filed 2026-03-20 | $2.76M derived: sum of 3 quarters · filed 2026-08-17 | $3.23M 10-K · filed 2026-03-20 |
| 2025-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $1.82M derived: sum of 2 quarters · filed 2026-08-17 | $2.30M 10-Q · filed 2025-11-19 | $2.84M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $671.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $1.15M 10-Q · filed 2026-08-17 | $1.68M derived: sum of 3 quarters · filed 2026-08-17 | $2.43M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $474.49K 10-Q · filed 2026-05-19 | $1.01M derived: sum of 2 quarters · filed 2026-05-19 | $1.76M derived: sum of 3 quarters · filed 2026-05-19 | $2.07M derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-31 | $538.53K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $1.29M derived: sum of 2 quarters · filed 2026-03-20 | $1.60M derived: sum of 3 quarters · filed 2026-03-20 | $1.56M 10-K · filed 2026-03-20 |
| 2024-09-30 | $749.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $1.06M derived: sum of 2 quarters · filed 2025-11-19 | $1.03M 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $308.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $276.99K 10-Q · filed 2025-08-19 | ||
| 2024-03-31 | -$31.58K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $1.78M 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |